ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,112Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 98

$1.4M Total Retail Price of All Prescriptions

Rank: 7 out of 98

333 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 333 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 13,167 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$99 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
NAMENDA 899 892 1 18
CRESTOR 689 625 2 51
FUROSEMIDE 492 483 3 4
EXELON 482 482 4 77
LEVOTHYROXINE SODIUM 448 429 5 5
OMEPRAZOLE 390 365 6 6
ESCITALOPRAM OXALATE 362 352 7 60
METOPROLOL SUCCINATE 357 352 8 16
WARFARIN SODIUM 340 293 9 1
RAMIPRIL 295 289 10 109
TRAZODONE HCL 292 292 11 9
DONEPEZIL HCL 289 278 12 12
MIRTAZAPINE 285 285 13 11
BYSTOLIC 279 252 14 157
AMLODIPINE BESYLATE 274 253 15 7
CELEBREX 222 222 16 119
CHLORTHALIDONE 201 201 17 138
ONGLYZA 197 157 18 159
PANTOPRAZOLE SODIUM 195 191 19 42
BISOPROLOL FUMARATE 191 177 20 184
LIDODERM 175 173 21 29
LISINOPRIL 153 142 22 3
POLYETHYLENE GLYCOL 3350 152 147 23 33
SPIRONOLACTONE 147 142 24 71
ADVAIR DISKUS 147 127 24 32
TAMSULOSIN HCL 138 128 26 25
SPIRIVA 128 110 27 46
METFORMIN HCL 123 110 28 15
OLANZAPINE 115 98 29 24
ARICEPT 112 112 30 222
TRAMADOL HCL 111 106 31 26
ATORVASTATIN CALCIUM 106 106 32 20
GABAPENTIN 106 101 32 13
ABILIFY 102 102 34 66
CITALOPRAM HBR 96 76 35 10
XARELTO 95 87 36 239
PRADAXA 93 93 37 241
LEXAPRO 92 91 38 245
LEVETIRACETAM 88 75 39 38
DIGOXIN 88 88 39 40
METFORMIN HCL ER 88 69 39 139
CLOPIDOGREL 87 86 42 50
PLAVIX 85 82 43 76
ENABLEX 81 73 44 250
FINASTERIDE 80 72 45 49
METOPROLOL TARTRATE 79 79 46 8
SIMVASTATIN 78 78 47 2
LYRICA 76 63 48 133
SERTRALINE HCL 76 53 48 19
RISPERIDONE 74 74 50 27
DIVALPROEX SODIUM 66 61 51 22
IRBESARTAN 64 59 52 267
ACTOS 63 51 53 154
CYMBALTA 63 63 53 47
QUETIAPINE FUMARATE 62 62 55 23
IPRATROPIUM-ALBUTEROL 62 60 55 45
LANTUS 59 46 57 28
BUMETANIDE 57 57 58 124
AZITHROMYCIN 56 53 59 104
VITAMIN D2 56 56 59 182
AMITIZA 56 56 59 282
OXYCODONE HCL 50 40 S2 62 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.